Prediction of depression 6 months to 3 years after treatment of head and neck cancer
- 6 September 2001
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 23 (10) , 892-898
- https://doi.org/10.1002/hed.1129
Abstract
Background Head and neck cancer and its treatment can have important psychosocial implications. Many patients become depressed. The aim of this prospective study is to examine whether pretreatment variables can be used to predict depression up to 3 years after treatment. Methods Head and neck cancer patients (n = 197) treated with surgery and/or radiotherapy completed both before and after treatment a questionnaire including items on social support, coping, depressive symptoms, physical functioning, and physical symptoms. Results Eight pretreatment variables (tumor stage, sex, depressive symptoms, openness to discuss cancer in the family, available appraisal support, received emotional support, tumor‐related symptoms, and size of the informal social network) were used to calculate a risk score to determine which patients were depressed at 6 months to 3 years after treatment (positive predicted value, 58%; negative predicted value, 83%). Conclusions Eight pretreatment variables can be used to predict accurately those head and neck cancer patients who are likely to become depressed up to 3 years after treatment. © 2001 John Wiley & Sons, Inc. Head Neck 23: 892–898, 2001.Keywords
This publication has 41 references indexed in Scilit:
- Long‐Term Quality of Life of Patients With Head and Neck CancerThe Laryngoscope, 2000
- Concerns, coping and quality of life in head and neck cancer patientsSupportive Care in Cancer, 1996
- Psychological distress in patients attending an oncology clinic after definitive treatment for maxillofacial malignant neoplasiaInternational Journal of Oral & Maxillofacial Surgery, 1993
- Prebiopsy Assessment of Patients with Suspected Head and Neck CancerJournal of Psychosocial Oncology, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Psycho-Oncology: Psychological Well·Being as One Component of Quality of LifePsychotherapy and Psychosomatics, 1993
- Gender and adjustment to chronic disease: A study of couples with colon cancerGeneral Hospital Psychiatry, 1989
- Factorial and discriminant validity of the center for epidemiological studies depression (CES-D) scaleJournal of Clinical Psychology, 1986
- Improving the detection of psychiatric problems in cancer patientsSocial Science & Medicine, 1985
- The CES-D ScaleApplied Psychological Measurement, 1977